Follow-up of patients with epidermodysplasia verruciformis treated with etretinate.
D000328:Adult; D004819:Epidermodysplasia Verruciformis / Q000188:drug therapy* / Q000382:microbiology; D005050:Etretinate / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D027383:Papillomaviridae / Q000302:isolation & purification
D005050:Etretinate